Turnbridge Capital
Turnbridge Capital, LLC, established in 2008, is a Dallas, Texas-based private equity firm with an additional office in Houston. It specializes in management buyouts, corporate spinouts, leveraged build-ups, and shareholder recapitalizations, focusing on middle market and later stage companies. Turnbridge primarily invests in the energy and infrastructure, industrial manufacturing and services, and transportation and distribution sectors within the United States, particularly in the southwest region. The firm seeks to invest between $25 million and $100 million in companies with enterprise values ranging from $50 million to $250 million, typically holding majority ownership for periods of three to seven years. Turnbridge Capital uses its personal capital for investments and does not target turnaround situations.
Top Stages
3 past transactions
Gradiant Energy Services
Venture Round in 2017
Gradiant Energy Services, established in 2012, is an oilfield services company specializing in water treatment for the oil and gas industry. Based in Denver, Colorado, with a regional office in Midland, Texas, the company caters to clients in the Permian and Marcellus shale plays. Gradiant's services include bacteria treatment, reusable clean brine, evaporative disposal, freshwater and desalination, and brine collection. It serves exploration and production (E&P) operators, helping them manage and treat flowback and produced water in a safe, reliable, and environmentally conscious manner.
Cimarron Energy
Acquisition in 2014
Cimarron Energy Inc is a company specializing in the engineering and manufacturing of emissions control solutions aimed at reducing greenhouse gas emissions across various industries. The company produces a range of equipment, including vapor recovery units, combustors, and other systems designed to manage and mitigate emissions. In addition to its manufacturing capabilities, Cimarron Energy provides compliance services and maintains safety plans, demonstrating its commitment to regulatory adherence. The company has also expanded its market presence through strategic acquisitions, such as Hy-Bon/EDI, which enhances its expertise in vapor recovery and emissions control. With over three decades of experience, Cimarron Energy is recognized for its innovative engineering approach and dedication to quality, ensuring that its products meet the specific needs of customers in the oil and gas sector while promoting environmentally responsible practices.
Morphotek
Series B in 2001
Morphotek, established in 2000, is a prominent life science company specializing in developing novel biological products to combat cancer, inflammation, and infectious diseases. The company's core technology, morphogenics, was co-invented by its current President and CEO, Dr. Nicholas Nicolaides, during his postgraduate research at Johns Hopkins Medical School. Morphotek focuses on discovering and developing monoclonal antibodies (mAbs) using this proprietary technology to treat various conditions such as ovarian and pancreatic cancers, rheumatoid arthritis, and asthma. The company conducts independent research and clinical development programs for its drug candidates.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.